The Latest Breaking News from FDA

If the case succeeds, it could have sweeping repercussions — for abortion providers and patients across the nation, as well as for the FDA's drug-approval process.

U.S. District Matthew Kacsmaryk was once deputy counsel for the First Liberty Institute, the Plano-based conservative Christian law firm.

While the FDA keeps experimental treatments out of reach, the spoonie world makes a diagnosis into an identity.

A federal judge will hear arguments in a high-stakes court case that could threaten access to medication abortion and blunt the authority of U.S. drug regulators

Experts say these should be considered long-term medications.

Each year, the DEA sets production limits for certain drugs, including some ingredients in common amphetamine pills like Adderall.

Matthew Kacsmaryk's actions ahead of a hearing planned for Wednesday were "bordering on judicial misconduct"

A group of 12 Democratic state attorneys general filed a lawsuit in the United States District Court for the Eastern District of Washington against the Food and Drug Administration (FDA) on Feb. 23, 2023, arguing that the agency’s regulations on the abortion-inducing drug mifepristone violate state sovereignty by limiting the…

Erythritol, a popular alternative to sugar, may increase risk of stroke. Is any fake sugar safe?